Stryker (SYK) Shares Outstanding (Weighted Average) (2009 - 2026)
Stryker (SYK) reported Shares Outstanding (Weighted Average) of $382.9 million for Q1 2026, little changed year-over-year from $381.7 million in Q1 2025, and little changed quarter-over-quarter from $382.2 million in Q4 2025.
Stryker (SYK) Shares Outstanding (Weighted Average) (2009 - 2026) Analysis & Trends
Stryker (SYK) has 18 years of Shares Outstanding (Weighted Average) data on file, last reported at $382.9 million in Q1 2026.
- Shares Outstanding (Weighted Average) for Q1 2026 came in at $382.9 million, changed 0.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $382.9 million (changed 0.31% YoY), and the FY2025 annual result was $382.2 million, changed 0.31% from the prior year.
- Shares Outstanding (Weighted Average) held at $382.9 million in Q1 2026 per SYK's latest filing, from $382.2 million in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $382.9 million in Q1 2026 and troughed at $377.7 million in Q1 2022.
- A 5-year average of $380.3 million and a median of $380.4 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
- On a YoY basis, Shares Outstanding (Weighted Average) climbed as much as 0.45% in 2023 and fell as far as 0.29% in 2023.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $378.2 million in 2022, then climbed by 0.37% to $379.6 million in 2023, then increased by 0.37% to $381.0 million in 2024, then advanced by 0.31% to $382.2 million in 2025, then increased by 0.18% to $382.9 million in 2026.
- Business Quant data shows SYK's Shares Outstanding (Weighted Average) at $382.9 million in Q1 2026, $382.2 million in Q4 2025, and $382.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 195.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 382.90 Mn |
| Dec 31, 2025 | 382.20 Mn |
| Sep 30, 2025 | 382.40 Mn |
| Jun 30, 2025 | 382.20 Mn |
| Mar 31, 2025 | 381.70 Mn |
| Dec 31, 2024 | 381.00 Mn |
| Sep 30, 2024 | 381.10 Mn |
| Jun 30, 2024 | 381.00 Mn |
| Mar 31, 2024 | 380.40 Mn |
| Dec 31, 2023 | 379.60 Mn |
| Sep 30, 2023 | 379.80 Mn |
| Jun 30, 2023 | 379.40 Mn |
| Mar 31, 2023 | 379.00 Mn |
| Dec 31, 2022 | 378.20 Mn |
| Sep 30, 2022 | 378.10 Mn |
| Jun 30, 2022 | 378.30 Mn |
| Mar 31, 2022 | 377.70 Mn |
| Dec 31, 2021 | 377.00 Mn |
| Sep 30, 2021 | 376.80 Mn |
| Jun 30, 2021 | 376.90 Mn |